CH646163A5 - Thromboxananaloge. - Google Patents

Thromboxananaloge. Download PDF

Info

Publication number
CH646163A5
CH646163A5 CH170980A CH170980A CH646163A5 CH 646163 A5 CH646163 A5 CH 646163A5 CH 170980 A CH170980 A CH 170980A CH 170980 A CH170980 A CH 170980A CH 646163 A5 CH646163 A5 CH 646163A5
Authority
CH
Switzerland
Prior art keywords
radical
formula
compounds
carbon atoms
methyl
Prior art date
Application number
CH170980A
Other languages
German (de)
English (en)
Inventor
Douglas Ross Jun Morton
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CH646163A5 publication Critical patent/CH646163A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/178Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1782Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
CH170980A 1979-03-12 1980-03-04 Thromboxananaloge. CH646163A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/019,752 US4243592A (en) 1979-03-12 1979-03-12 9,11-Dideoxy-10-oxa-TXB compounds

Publications (1)

Publication Number Publication Date
CH646163A5 true CH646163A5 (de) 1984-11-15

Family

ID=21794849

Family Applications (1)

Application Number Title Priority Date Filing Date
CH170980A CH646163A5 (de) 1979-03-12 1980-03-04 Thromboxananaloge.

Country Status (9)

Country Link
US (1) US4243592A (enExample)
JP (1) JPS55127385A (enExample)
BE (1) BE882196A (enExample)
CH (1) CH646163A5 (enExample)
DE (1) DE3006708A1 (enExample)
FR (1) FR2451374A1 (enExample)
GB (2) GB2046733B (enExample)
IT (1) IT8048063A0 (enExample)
NL (1) NL8001318A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8330094D0 (en) * 1983-11-11 1983-12-21 Ici Plc Diphenyl compounds
EP0346511A1 (en) * 1988-06-15 1989-12-20 Fujisawa Pharmaceutical Co., Ltd. Oxygen-containing hererocyclic compound, processes for their preparation and pharmaceutical compositions comprising them
JP4712378B2 (ja) * 2002-06-05 2011-06-29 俊夫 小室 抗血栓性を有する白金含有セラミックス組成物及びそれを含む物品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1046016B (de) * 1956-10-13 1958-12-11 Merck Ag E Verfahren zur Herstellung von 6,8-Dihydroxy-n-octansaeure-1
NL128798C (enExample) * 1965-07-07
DE1493572A1 (de) * 1965-12-02 1969-11-13 Huels Chemische Werke Ag Verfahren zur Herstellung von Cycloacetal- und Cycloketalestern
US3505386A (en) * 1965-12-29 1970-04-07 Upjohn Co Compounds related to prostaglandins

Also Published As

Publication number Publication date
GB2046733A (en) 1980-11-19
GB2064539B (en) 1982-12-22
BE882196A (fr) 1980-09-12
DE3006708A1 (de) 1980-09-25
JPS55127385A (en) 1980-10-02
FR2451374A1 (fr) 1980-10-10
FR2451374B1 (enExample) 1983-08-26
IT8048063A0 (it) 1980-03-03
GB2046733B (en) 1983-03-16
NL8001318A (nl) 1980-09-16
US4243592A (en) 1981-01-06
GB2064539A (en) 1981-06-17

Similar Documents

Publication Publication Date Title
DE3153474C2 (enExample)
CH647222A5 (de) 9-desoxy-9a-methylen-isostere von pgi-2 und verfahren zu deren herstellung.
DE3832570A1 (de) 7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
EP0055208A2 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0119949B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2365035A1 (de) Prostaglandin-analoge
DE2229035A1 (de) Cyclopentanderivate
DE2437622A1 (de) Cyclopentanderivate
EP0099538B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE4024347A1 (de) Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE2234709C2 (de) Prostanoesäurederivate und Verfahren zu deren Herstellung
EP0069692B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DD220204A5 (de) Verfahren zur herstellung von 5-cyanoprostacylinen
CH643839A5 (de) Prostacyclinanaloge.
DE3006708A1 (de) Thromboxananaloge und thromboxanzwischenprodukte
EP0086404B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2337581A1 (de) Derivate von 9-hydroxy-13-trans-prostensaeure
WO1983003248A1 (en) Carbacycline, preparation and utilization thereof
CH623570A5 (enExample)
DE3234253A1 (de) (11r)-11-desoxy-11-alkyl-6-oxo-pg-artige verbindungen
DE2716075A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan-analoga
DE2917456A1 (de) Imidazolderivate und ihre ungiftigen salze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzung
CH638195A5 (de) Prostacyclinanaloge.
EP0113311B1 (de) 5-Fluorcarbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2640692C3 (de) Optisch aktive 5- (2-Carboxythiophen5-yl)-16phenoxy- a -tetranor- w tetranor-prostaglandine

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased